ArticleCellular & molecular immunology2018

LYVE-1 is 'on stage' now: an emerging player in dendritic cell docking to lymphatic endothelial cells.

Elena Rinaldi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.